首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >Double‐blind randomized clinical trial assessing the efficacy and safety of early initiation of sitagliptin during metformin uptitration in the treatment of patients with type 2 diabetes: The CompoSIT‐M study

【2h】

Double‐blind randomized clinical trial assessing the efficacy and safety of early initiation of sitagliptin during metformin uptitration in the treatment of patients with type 2 diabetes: The CompoSIT‐M study

机译：一项双盲随机临床试验评估西他列汀在二甲双胍增高期间早期治疗2型糖尿病患者的疗效和安全性：CompoSIT-M研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

AimsTo characterize the glycaemic efficacy and safety of initiation of the dipeptidyl peptidase‐4 inhibitor sitagliptin during metformin dose escalation in people with type 2 diabetes (T2D) not at glycated haemoglobin (HbA1c) goal on a sub‐maximal dose of metformin.

机译：目的表征2型糖尿病（T2D）患者中二甲双胍肽酶4抑制剂西他列汀的血糖控制效果和安全性，该研究并未以低于二甲双胍最大剂量的糖化血红蛋白（HbA1c）为目标。

著录项

期刊名称 Wiley-Blackwell Online Open
作者
Juan P. Frias; Zachary Zimmer; Raymond L.H. Lam; Guillermo Amorin; Catherine Ntabadde; Carol Iredale; Edward A. ONeill; Samuel S. Engel; Keith D. Kaufman; Hideo Makimura; Michael F. Crutchlow;
展开▼
作者单位

展开▼
年(卷),期 -1(21),5
年度 -1
页码 1128–1135
总页数 8
原文格式 PDF
正文语种
中图分类
关键词
sitagliptin metformin type 2 diabetes randomised trial;

机译：西他列汀;二甲双胍;2型糖尿病;随机试验;

相似文献

外文文献
中文文献
专利

1. Double‐blind, randomized clinical trial assessing the efficacy and safety of early initiation of sitagliptin during metformin uptitration in the treatment of patients with type 2 diabetes: The CompoSIT‐M study [J] . Frias Juan P., Zimmer Zachary, Lam Raymond L.H., Diabetes, obesity & metabolism . 2019,第5期

机译：双盲，随机临床试验评估SITAGLIPTIN期间SITAGLIPTIN早期起始的疗效和安全性在治疗2型糖尿病患者中的患者：复合材料研究
2. Double‐blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase‐4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT‐I Study [J] . Roussel Ronan, Duran‐García Santiago, Zhang Yilong, Diabetes, obesity & metabolism . 2019,第4期

机译：双盲，随机临床试验比较持续或停止二肽基肽酶-4抑制剂SITAGLIPTIN在2型糖尿病患者患者中的疗效和安全性的疗效和安全性：复合材料 - 我的研究
3. HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin [J] . AhrénB., JohnsonS.L., StewartM., Diabetes care . 2014,第8期

机译：和谐3：一项104周的随机，双盲，安慰剂和活性对照试验评估了阿比鲁肽与安慰剂，西他列汀和格列美脲相比在服用二甲双胍的2型糖尿病患者中的有效性和安全性
4. A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL TO INVESTIGATE THE EFFICACY OF TIAMULIN IN THE CONTROL OF PORCINE PROLIFERATIVE ENTEROPATHY (PPE) AND PORCINE COLONIC SPIROCHAETOSIS (PCS) UNDER FIELD CONDITIONS [C] . J. Haugegaard, K. Moller, T.K. Jensen, Congress of the International Pig Veterinary Society . 2000

机译：一种双盲随机安慰剂对照临床试验，探讨硫霉素在野生植物中猪增殖肠病（PPE）和猪结肠螺旋肌肤症（PCS）的疗效
5. Efficacy of the Chinese herbal formula CUF2 in the treatment of childhood asthma: Animal experiment, in vitro study and randomized, double-blinded, placebo-controlled clinical trial. [D] . Wong, Yeuk Oi. 2006

机译：中药配方CUF2在治疗儿童哮喘中的功效：动物实验，体外研究以及随机，双盲，安慰剂对照的临床试验。
6. Double‐blind randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase‐4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT‐I Study [O] . Ronan Roussel, Santiago Duran‐García, Yilong Zhang, -1

机译：一项双盲随机临床试验比较了在2型糖尿病患者中开始胰岛素甘精胰岛素治疗时继续或终止二肽基肽酶-4抑制剂西他列汀的疗效和安全性：CompoSIT-I研究
7. HARMONY 3: 104-Week Randomized, Double-Blind, Placebo- and Active-Controlled Trial Assessing the Efficacy and Safety of Albiglutide Compared With Placebo, Sitagliptin, and Glimepiride in Patients With Type 2 Diabetes Taking Metformin. [O] . Ahrén, Bo, Johnson, Susan L, Stewart, Murray, 2014

机译：HaRmONY 3：104周随机，双盲，安慰剂和活性对照试验评估albiglutide与安慰剂，西他列汀和格列美脲治疗2型糖尿病患者服用二甲双胍的疗效和安全性。

Double‐blind randomized clinical trial assessing the efficacy and safety of early initiation of sitagliptin during metformin uptitration in the treatment of patients with type 2 diabetes: The CompoSIT‐M study

摘要

著录项

相似文献

相关主题

期刊订阅